# Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients

> **NCT00965341** · PHASE3 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 53 (actual)

## Conditions studied

- Advanced Cancer

## Interventions

- **DRUG:** Testosterone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00965341
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2016-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00965341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00965341, "Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00965341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*